Arrowhead Pharmaceuticals (ARWR) Construction in Progress (2021 - 2023)

Arrowhead Pharmaceuticals' Construction in Progress history runs 3 years deep, the most recent figure standing at $166.7 million for Q3 2023.

• Quarterly Construction in Progress rose 195.63% year-over-year to $166.7 million in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $166.7 million (up 195.63% YoY) and the FY2023 annual result came in at $166.7 million, up 195.63% from the prior year.
• Construction in Progress was $166.7 million for Q3 2023 at Arrowhead Pharmaceuticals, up from $118.3 million in the prior quarter.
• Across five years, Construction in Progress topped out at $166.7 million in Q3 2023 and bottomed at $345000.0 in Q3 2021.
• A 3-year average of $65.6 million and a median of $56.4 million in 2022 frame the typical range for Construction in Progress.
• Annual changes were most pronounced in 2022 — Construction in Progress surged 16240.0% — and 2023, when it jumped 195.63%.
• Arrowhead Pharmaceuticals' Construction in Progress stood at $2.2 million in 2021, then jumped by 4092.15% to $90.2 million in 2022, then soared by 84.73% to $166.7 million in 2023.
• Business Quant data shows ARWR's Construction in Progress at $166.7 million in Q3 2023, $118.3 million in Q2 2023, and $127.2 million in Q1 2023.